"10.1371_journal.pmed.1001796","plos medicine","2015-03-03T00:00:00Z","Ana-Carolina Martinez-Torres; Claire Quiney; Tarik Attout; Helo√Øse Boullet; Linda Herbi; Laura Vela; Sandrine Barbier; Danielle Chateau; Elise Chapiro; Florence Nguyen-Khac; Fr√©d√©ric Davi; Magali Le Garff-Tavernier; Roba Moumn√©; Marika Sarfati; Philippe Karoyan; H√©l√®ne Merle-B√©ral; Pierre Launay; Santos A Susin","Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, INSERM UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Sorbonne Universit√©s, Universit√© Pierre et Marie Curie Paris 6, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Universit√© Paris Descartes, Sorbonne Paris Cit√©, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; INSERM U1149, Paris, France; Facult√© de M√©decine, Site Xavier Bichat, Universit√© Paris Diderot, Sorbonne Paris Cit√©, Paris, France; Laboratoire des Biomol√©cules, UMR 7203 and FR 2769, Sorbonne Universit√©s, Universit√© Pierre et Marie Curie, Paris, France; Centre National de la Recherche Scientifique, UMR 7203, Paris, France; D√©partement de Chimie, √âcole Normale Sup√©rieure, Paris, France; Intestine: Nutrition, Barrier, and Diseases Team, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Service d‚ÄôH√©matologie Biologique, Groupe Hospitalier Piti√©-Salp√™tri√®re, Assistance Publique‚ÄH√¥pitaux de Paris, Paris, France; Immunoregulation Laboratory, Centre de Recherche du Centre Hospitalier de l‚ÄôUniversit√© de Montr√©al, Montr√©al, Quebec, Canada","Conceived and designed the experiments: ACMT CQ TA LH LV SB DC PK HMB PL SAS. Performed the experiments: ACMT CQ TA HB LH LV SB DC PK. Analyzed the data: ACMT CQ TA HB LH LV SB DC MS PK HMB PL SAS. Contributed reagents/materials/analysis tools: HB EC FNK FD MLGT RM MS PK HMB SAS. Enrolled patients: FNK HMB. Peptide design: PK. Wrote the paper: ACMT MS PK HMB PL SAS. ICMJE criteria for authorship read and met: ACMT CQ TA HB LH LV SB DC EC FNK FD MLGT RM MS PK HMB PL SAS. Agree with manuscript results and conclusions: ACMT CQ TA HB LH LV SB DC EC FNK FD MLGT RM MS PK HMB PL SAS.","The patent applications PCT/EP2013/061727 and PCT/EP2014/077335 included results from this paper. The authors declare that no other competing interests exist.","2015","03","Ana-Carolina Martinez-Torres","ACMT",18,TRUE,11,9,13,6,TRUE,TRUE,FALSE,0,NA,FALSE
